Dr Mark Cohen MD FACS
Professor of Surgery, Pharmacology, and Biomedical Engineering - University of Michigan, US
Dr Mark Cohen is currently Professor of Surgery, Pharmacology, and Biomedical Engineering at the University of Michigan. He is also the Vice Chair in Surgery for Clinical Operations, Executive Director of the Michigan Surgical Innovation Prize Fund, and Director of the Medical School Pathway of Excellence in Innovation and Entrepreneurship.
He received his bachelors in Chemical Engineering and his Medical Doctorate degrees from Washington University in St. Louis and completed his general surgery residency as well as a NIH-sponsored fellowship in endocrine and oncologic surgery at Barnes-Jewish Hospital. Before coming to the University of Michigan in 2012, he was Vice-Chair for Research in the Department of Surgery at the University of Kansas. While he served as Associate Chair in Surgery for Innovation and Entrepreneurship in the Department of Surgery, he helped create several opportunities and programs to engage faculty, residents, and students in innovation efforts leading to over $700,000 in follow-on funding and formation of two start-up companies in the last year. He has written and published over 100 original articles, 11 book chapters, and a textbook in 2019 titled "Success in Academic Surgery: Innovation and Entrepreneurship" from Springer NATURE, and his research has been externally funded on three NIH R-01 research grants as well as by the Susan G. Komen Foundation, the American Cancer Society, Industry grants, as well as gifts from grateful patient donors. He has served on Grant Study Sections for the NCI, the National Science Foundation, the DOD, and the Susan G. Komen Foundation, as well as serving on the Executive Council of the Association for Academic Surgery and the American Association for Endocrine Surgeons as the National Program Chair in 2013.
Regarding his work on Surgical Innovation, Mark has personally co-founded four startup companies over the last decade, and has developed education programs in medical innovation for surgeons, residents, medical students and graduate students, now training over 400 medical professionals since 2016. He currently directs the only medical student pathway of excellence in Innovation and Entrepreneurship in the world which has lead to eight medical student startups, 23 patent applications, and 11 national pitch competition winners.
Mark was recently awarded the 2019 Distinguished Faculty Recognition Award by the University of Michigan for his efforts in Innovation. His research is in novel drug development and nanoparticle drug delivery systems for endocrine malignancies as well as novel implantable tissue regeneration techniques. Finally his clinical efforts are focused in complex endocrine surgery and are nationally recognized and he is Boarded by the American Board of Surgery and is a Fellow of the American College of Surgeons.